Teach patients about ARESTIN® on your practice's Web site

More and more practices are requesting tools they can use on their Web sites to inform patients about periodontal disease, and their use of ARESTIN® to fight it.
Patients want to know more about the seriousness of periodontal disease, and your personal standard of care for comprehensive treatment. Place a free banner ad, ARESTIN® logo, video, or ARESTIN® product description on your practice's site to link patients to Arestin.com. Help patients get the information they need and assure them they are not facing this infection alone.
Be sure to link the ARESTIN® banner or logo on your Web page to www.Arestin.com. For more information about using these materials please refer to www.w3schools.com and your Web site developer.

Banner Ads

These banners match the theme of the most recent print patient education materials available to you.
Banner Ad

Logos

These are an alternative to the banners, providing a quick mention of ARESTIN® if your site has no room for a banner. Also, add the ARESTIN® logo to your list of products available in your practice.

ARESTIN® Product Description

This is a description of ARESTIN® to use on your practice's site. It explains the science and benefits of ARESTIN® therapy in patient-friendly language.

Periodontal disease is a serious infection under your gumline.
ARESTIN® (minocycline hydrochloride) is an antibiotic that kills the bacteria that cause the infection.
  1. It's placed directly in the infected areas—or "pockets"—in your gums.
  2. It's applied right after scaling and root planing, the dental procedure that disrupts stubborn plaque and bacteria below your gumline—where brushing and flossing can't reach.
ARESTIN® starts working quickly, right at the source of infection, and keeps fighting bacteria long after you leave the dental office.1,2
ARESTIN® fights infection and inflammation for 30 days,2 and provides significantly better results than SRP alone for up to 90 days.3
References: 1. Oringer RJ, Al-Shammari KF, Aldredge WA, et al. Effect of locally administered minocycline microspheres on markers of bone resorption. J Periodontol 2002;73:835-842. 2. Goodson JM, Gunsollwy JC, Grossi SG, et al. Minocycline HCl microspheres reduce red-complex bacteria in periodontal disease therapy. J Periodontol 2007;78(8):1568-1579. 3. Williams RC, Paquette DW, Offenbacher S, et al. Treatment of periodontitis by local administration of minocycline microspheres: a controlled trial. J Periodontol 2001;72:1535-1544.

Videos

These videos are short, effective visual ways to provide information to patients on periodontal disease and treatment with ARESTIN®. Videos will download as .swf files and are suitable for web use.

How ARESTIN® Works
An animation explaining the presence of bacteria, demonstrating SRP and administration of ARESTIN®, and healing of infection over time.
Your Health Today "Newscast"
A dentist explains ARESTIN® therapy and a patient describes her experience. A healthcare reporter hosts this TV–news–style video.
Preview
|
Download
Preview
|
Download
By accessing the promotional materials on this web site you agree that you are accepting a limited license for use with no ownership rights for the materials and the content therein. You further agree that you will not alter or manipulate the content in any way but use the materials as presented herein.

Video not available

S. Smith, RDH
McLean, VA

View All Videos In Library »

Lay the foundation for improved outcomes

Less than 30% of all practices regularly probe and chart, yet over 60% of patients have periodontal infections. Learn how routine evaluation and diagnosis mean better productivity and outcomes.

Learn from an expert

See how one dental professional handles objections about treating periodontal disease from a patient. Watch an ARESTIN®-Certified Expert describe periodontal disease to a reluctant patient in the Patient Communication section.

INDICATION

ARESTIN® is indicated as an adjunct to scaling and root planing (SRP) procedures for reduction of pocket depth in patients with adult periodontitis. ARESTIN® may be used as part of a periodontal maintenance program, which includes good oral hygiene and SRP.

IMPORTANT SAFETY INFORMATION

ARESTIN® should not be used in any patient who has a known sensitivity to minocycline or tetracyclines. The use of drugs of the tetracycline class during tooth development may cause permanent discoloration of the teeth, and therefore should not be used in children or in pregnant or nursing women. Hypersensitivity reactions that included, but were not limited to, anaphylaxis, angioneurotic edema, urticaria, rash, swelling of the face and pruritus have been reported with the use of ARESTIN®. In clinical trials, the most frequently reported nondental treatment-emergent adverse events were headache, infection, flu syndrome and pain.

Please see Full Prescribing Information

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Contact us with questions about your account or MyArestin.com®